Arrive AI and Hancock Health Launch Robotic Medical Deliveries at Hancock Regional Hospital
Groundbreaking Automation Poised to Deliver Enhanced Efficiency and Patient Care
Marks Arrive AI's First Revenue Generating Arrive PointTM Deployment
GREENFIELD, INDIANA / ACCESS Newswire / May 19, 2025 / Arrive AI (NASDAQ:ARAI), a pioneering autonomous delivery network anchored by patented AI-powered Arrive Points™, and Hancock Health, a regional hospital and member of the Mayo Clinic Care Network located in Greenfield, IN, today announced the launch of a two-year partnership. The agreement marks Arrive AI's first revenue generating deployment. The collaboration will explore the transformative potential of asynchronous robotic automation for medical deliveries within hospitals, aiming to unlock significant cost savings through technological advancements and operational efficiencies using Arrive AI technology.
Operations began today with the Arrive Point, as Arrive AI's secure and patented autonomous delivery station took center stage. This innovative device will serve as a reliable, chain-of-custody-compliant hub for the seamless drop-off and pickup of biospecimens from the cancer center.
This partnership places Hancock Health at the forefront of autonomous medical logistics, with potential applications across its broader network of more than 30 locations in East Central Indiana.
"At Hancock Health, our top priority is delivering personalized and high-quality care in the most affordable and efficient way possible," said Steve Long, President and CEO of Hancock Health. "Embracing automation opens the door to transformative improvements - reducing costs, accelerating the delivery of critical items like test results, medications, and lab specimens, and strengthening the security and reliability of our services. Every improvement in these areas enhances the overall patient experience."
Dan O'Toole, CEO of Arrive AI, commented, "This live deployment marks a significant milestone for Arrive AI as we move from pilot programs to generating revenue and demonstrating the real-world value of our autonomous delivery solutions. We are eager to collaborate closely with Hancock Health and validate the tangible benefits Arrive AI will bring to their operations."
Hancock Health has identified operational inefficiencies that include having medical personnel make more than a dozen daily trips between its clinics and hospital lab to deliver specimens. Those trips pull staff from critical duties, delay lab results and increase labor costs. The multi-phase test with Arrive AI will showcase how cutting edge, asynchronous technology is set to change the healthcare landscape in a seismic way.
The phased rollout of the initiative includes: a comprehensive readiness evaluation; the installation of robotic technology at the hospital's Sue Ann Wortman Cancer Center and laboratory; the development of optimized delivery routes; the expansion of technology deployment to off-campus locations; and the introduction of drone-based transport for time-sensitive and off-site medical deliveries. Each phase will incorporate the Arrive Point, providing a standardized and secure interface for all chain-of-custody transfers.
According to the terms of the agreement, Arrive AI anticipates leveraging the insights gained from this trial by September 2027 to develop a scalable framework for integrating ground robotics, courier networks, and drones across Hancock Health's entire network. Arrive AI will spearhead the design, deployment, and optimization of this integrated system, ensuring regulatory compliance, operational feasibility, and a validated return on investment. Key strategies for enhancing efficiency and reliability include:
Replacing manual specimen transport with robotic automation.Providing Arrive Point storage devices for round-the-clock deliveries.Deploying drones for urgent and off-campus transport needs.
-30-
About Arrive AI: Arrive AI's patented last mile (ALM) platform enables drone-based and human mail delivery to and from a physical smart mailbox, while providing tracking data, smart logistics alerts, and advanced chain of custody controls to secure the last-mile delivery for all shippers, delivery services, and autonomous delivery networks. Arrive AI makes the exchange of goods between people, robots, and drones frictionless, efficient, and convenient through artificial intelligence, autonomous technology, and interoperability with smart devices including doorbells, lighting and security systems. Learn more details about the company's patents here. See videos of the smart mailbox in action here.
About Hancock Health: Hancock Health, a Mayo Clinic Care Network Member, is a full-service healthcare network serving East Central Indiana at Hancock Regional Hospital and more than 30 other locations to ensure convenience to high quality care. A member of the Suburban Health Organization (SHO) and partner to Peyton Manning Children's Hospital, Hancock Health believes in the power of partnerships to lower costs and improve health outcomes for patients. Hancock Health's expert physicians have access to Mayo Clinic's research, diagnostic, and treatment resources across specialties including cancer care, women's health, primary care, wellness, emergency medicine, and more - all with the goal of improving health outcomes and making health possible for East Central Indiana. Media Contact: Claire Hunter: claire@pencemediagroup.com
Cautionary Note Regarding Forward Looking Statements
This news release and statements of Arrive AI's management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "plans", "believes", "potential", "will", "should", "could", "would" ,"optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI's Registration Statement for more complete information, including the risk factors that may affect future results, which are available for review at https://www.sec.gov/ Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
Media contact: Cheryl Reed, media@arriveai.comInvestor Relations Contact: Alliance Advisors IR, ARAI.IR@allianceadvisors.com
SOURCE: Arrive AI Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
HostColor Expands Its AMD Dedicated Server Offerings in LA and New York
(HC) has announced the immediate availability of bare metal servers powered by AMD Ryzen and AMD EPYC processors in several new data center locations in Los Angeles and New York City. - AMD Dedicated Servers in Los Angeles and New York New York, New York, June 14, 2025 (GLOBE NEWSWIRE) -- (HC) has announced the immediate availability of bare metal servers powered by AMD Ryzen and AMD EPYC processors in several new data center locations. (HC), a globally recognized provider of cloud infrastructure and managed services, has announced the availability of custom-built, high-bandwidth, high-performance AMD dedicated server platforms in several new data center locations. HostColor's new primary New York City service location for delivering AMD CPU-powered servers is the DataBank data center, located at 111 Eighth Avenue in Downtown Manhattan in a telecommunications building owned by Google. Other new data center locations for delivering AMD CPU-powered bare metal servers include Equinix LA3 and CoreSite LA2 in Los Angeles. The available AMD Ryzen processors at HostColor's new Manhattan, NYC service location are the Ryzen 9 5950X, Ryzen 9 7950X, Ryzen 9 9950X, and Ryzen Threadripper Pro 7965WX. The available server platforms with AMD EPYC CPUs feature: AMD EPYC 7C13, AMD EPYC 7443P, AMD EPYC 7662, AMD EPYC 9274F, AMD EPYC 9275F, AMD EPYC 9374F, AMD EPYC 9474F, AMD EPYC 9654 and AMD EPYC 9754. Customers can customize their server configurations with IPv4 and IPv6 address space. They can also choose a network service with metered data transfer measured in terabytes (TB) transferred per month or unmetered bandwidth ports with allocations ranging from 100 Mbps to 10 Gbps. "Unmetered bandwidth" means that the hosting infrastructure provider does not measure or limit the bandwidth used by the server. For example, at most of its Edge data centers, HostColor allows customers to use the full capacity of their dedicated servers' physical internet bandwidth port. HostColor's AMD server customers benefit from unlimited data transfer up to the physical capacity of the internet connection ports. Unlike large hyperscale clouds, HostColor (HC) provides both Bare Metal Servers and dedicated cloud infrastructure with unmetered bandwidth ports and unlimited data transfer quotas, with no charges for inbound or outbound Internet traffic. Compared to the infrastructure offered by the major hyperscale clouds, HC's Dedicated Cloud Hosting and bare metal offerings save a tremendous amount of financial resources. HostColor does not charge its customers for internet traffic, IOPS, DNS lookups, DNS zones, internet traffic zones, or infrastructure technical support. All of HostColor's AMD-based server configurations provide customers with enterprise cloud computing and virtualization options, and they are compatible with Amazon Web Services (AWS), Microsoft Azure, Google Cloud, and other major cloud providers. HC's AMD processor-based servers can handle large data sets and are ideal for AI-driven applications, software automation platforms, and large, complex database management systems that require data processing. They are also well-suited for various HPC workloads. Free Infrastructure Technical Support HostColor does not charge for access to technical support for the core functionality of its dedicated cloud hosting infrastructure. The company provides dedicated cloud servers with "Free Infrastructure Technical Support" per Service Level Agreement (SLA). This support covers core service functionality related to network interfaces and the physical components of bare metal servers, such as CPUs, RAM, and storage drives. FITS also includes consultation on various infrastructure service use case scenarios. However, FITS does not cover maintenance and support for operating systems (OSs), custom configurations, or installed software applications. These are covered by the next level of SLA-defined technical support, Semi-Managed Dedicated Servers. This technical support agreement is based on the company's Edge Server hosting infrastructure platform. Semi-Managed Dedicated Servers In addition to FITS, all of HostColor's dedicated server hosting services are "Semi-Managed" by the SLA. The provider is responsible for installing and configuring server instances according to the customer's custom configurations for Linux infrastructure environments. Additionally, HC Support reinstalls the server operating system (OS) upon request, configures and manages network settings, creates and maintains custom virtual private networks, and assists customers with troubleshooting any server-side issues related to the OS, network, or software configuration. About HostColor Since 2000, (HC) has been a global provider of semi-managed edge, bare metal, and cloud infrastructure and IT hosting services. HC operates virtual data centers and provides dedicated hosting and colocation services from over 100 data centers worldwide. Its subsidiary, provides cloud infrastructure and dedicated hosting services in 19 European countries. For more information, visit Media Contact PR Department +1 888-222-1495 pr@ Attachment - AMD Dedicated Servers in Los Angeles and New YorkError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Indianapolis Star
39 minutes ago
- Indianapolis Star
New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP)
This week's episode is sponsored by The Sustainable Green Team's Waterless Garden (OTC:SGTM) and PetVivo Holdings, Inc.'s (NASDAQ:PETV) innovative SPRYNG™ product. NEW YORK CITY, NY / ACCESS Newswire / June 14, 2025 / New to The Street, the nationally syndicated business television series known for spotlighting innovation across sectors, announces the premiere of Episode #671 airing tonight on Bloomberg Television at 6:30 PM EST. This week's broadcast features five dynamic companies making waves across blockchain, AI, health tech, wellness, and pharmaceutical sectors: FLOKI – The globally recognized crypto and blockchain brand building Web3 utility through its DeFi ecosystem. Arrive AI (NASDAQ:ARAI) – Developer of a patented smart mailbox delivery platform, leading last-mile logistics innovation with its autonomous, AI-powered systems. Health In Tech (NASDAQ:HIT) – A pioneer in digital underwriting and quote-to-card technology for health insurance, transforming how plans are built and priced. Vita Bella – A wellness brand that continues to expand its national presence through health-focused lifestyle offerings. NRX Pharmaceuticals (NASDAQ:NRXP) – A late-stage pharmaceutical company advancing treatments for CNS disorders and respiratory distress. This week's featured corporate sponsors include: The Sustainable Green Team (OTC:SGTM) and its revolutionary Waterless Garden initiative for drought-resistant, sustainable landscaping. PetVivo Holdings, Inc. (NASDAQ:PETV), showcasing continued progress with its SPRYNG™, a veterinary injectable device for treating osteoarthritis in companion animals. Upcoming Highlights: New to The Street has also wrapped filming this week with several prominent brands: GLINT Pay (Private) – A disruptive gold-as-money platform allowing real-time gold transactions. Lahontan Gold Corp. (TSX.V:LG / OTCQB:LGCXF) – Canadian gold exploration company with high-grade assets in Nevada. Greer Consulting Group – Providing strategic solutions across regulatory compliance, M&A, and executive strategy. Special Feature Segment: A culinary showcase from two of New York City's most iconic dining destinations – Black Barn and Hunt & Fish Club – blending luxury hospitality with the business of restaurant branding. Additionally, special segments fromIMG Academy, Skip Barber Racing School, and KITON will continue to roll out in the coming months as part of New to The Street's ongoing coverage of elite performance, luxury, and innovation. Quote from Vince Caruso, Creator and Executive Producer of New to The Street: 'We continue to be a destination for innovative and publicly traded companies ready to tell their story at scale. Tonight's show blends AI, healthcare, crypto, and wellness with real national TV exposure. We're proud to feature these brands and grateful to our show sponsors for helping amplify their messages.' About New to The Street Since 2009, New to The Street has become one of the most trusted platforms for public and private companies to share their stories. The show combines sponsored programming with earned media, enhanced by iconic outdoor campaigns, nationwide TV commercials, and non-deal roadshows that connect executives with top-tier investors and institutions. With weekly reach across 220 million linear TV households, a growing 2.65 million YouTube subscribers, and a robust social media presence exceeding 700,000 followers across LinkedIn, Facebook, Instagram, and X, New to The Street delivers unparalleled exposure and credibility in the business media space. For more information, visit SOURCE: New To The Street View the original press release on ACCESS Newswire
Yahoo
41 minutes ago
- Yahoo
OKYO Pharma Limited's (NASDAQ:OKYO) market cap up US$38m last week, benefiting both individual investors who own 58% as well as insiders
OKYO Pharma's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public 42% of the business is held by the top 12 shareholders Insider ownership in OKYO Pharma is 36% We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. A look at the shareholders of OKYO Pharma Limited (NASDAQ:OKYO) can tell us which group is most powerful. We can see that individual investors own the lion's share in the company with 58% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Following a 58% increase in the stock price last week, individual investors profited the most, but insiders who own 36% stock also stood to gain from the increase. Let's take a closer look to see what the different types of shareholders can tell us about OKYO Pharma. View our latest analysis for OKYO Pharma Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. As you can see, institutional investors have a fair amount of stake in OKYO Pharma. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of OKYO Pharma, (below). Of course, keep in mind that there are other factors to consider, too. We note that hedge funds don't have a meaningful investment in OKYO Pharma. Gabriele Marco Cerrone is currently the largest shareholder, with 29% of shares outstanding. For context, the second largest shareholder holds about 6.8% of the shares outstanding, followed by an ownership of 5.9% by the third-largest shareholder. Our studies suggest that the top 12 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage. While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Our information suggests that insiders maintain a significant holding in OKYO Pharma Limited. Insiders have a US$37m stake in this US$102m business. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently. The general public, who are usually individual investors, hold a substantial 58% stake in OKYO Pharma, suggesting it is a fairly popular stock. This level of ownership gives investors from the wider public some power to sway key policy decisions such as board composition, executive compensation, and the dividend payout ratio. I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 4 warning signs we've spotted with OKYO Pharma (including 2 which make us uncomfortable) . If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
